For instance, in colorectal cancer patients, ACEis/ARBs therapy significantly enhanced PFS, particularly in those with left-sided colorectal cancer, due to the higher expression of AT1R in the left colon compared to the right [59]. The gene discussed is AGTR1; the disease is colorectal cancer.